Mind & Memory Newsbriefs

Article Excerpt

Mirtazapine Does Not Boost SSRI Effectiveness
When patients have residual symptoms of depression after at least six weeks of treatment with a selective serotonin reuptake inhibitor (SSRI) or serotonin-noradenaline reuptake inhibitor

Comments

Leave a Reply

×
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×
×

Please Log In

You are trying to access subscribers-only content. If you are a subscriber, use the form below to log in.

Subscribers will have unlimited access to the magazine that helps people live more sustainable, self-reliant lives, with feature stories on tending the garden, managing the homestead, raising healthy livestock and more!

This setting should only be used on your home or work computer.

×

Please Log In

You are trying to access subscribers-only content. If you are a subscriber, use the form below to log in.

Subscribers will have unlimited access to the magazine that helps the small-scale poultry enthusiast raise healthy, happy, productive flocks for eggs, meat or fun - from the countryside to the urban homestead!

This setting should only be used on your home or work computer.

Send this to a friend

Hi,
I thought you might be interested in this article on https://universityhealthnews.com: Mind & Memory Newsbriefs

-- Read the story at https://universityhealthnews.com/topics/depression-topics/mind-memory-newsbriefs/